Listar DAAPC-Artículos, capítulos... por autor "Wildsmith, Sophie"
Mostrando ítems 1-1 de 1
-
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
López-Beltrán, Antonio; López-Ríos, Fernando; Montironi, Rodolfo; Wildsmith, Sophie; Eckstein, Markus (MDPI, 2021)Immuno-oncology (IO) agents (anti–programmed cell death 1 (PD-1) and anti–programmed cell death-ligand 1 (PD-L1)) are approved as first- and second-line treatments for metastatic UC. PD-L1 expression levels in UC tumors ...